Biggest Challenge of 2017 Directly Ahead for Gold, Stocks
Blue Sky Uranium (BKUCF): Completes Geophysical Survey at Amarillo Grande Uranium Project
Gold Is Cheap Insurance No Matter What the Fed Will Do
Lomiko and Canada Strategic Intersect 110.8 metres of 14.56% and 135.6 metres of 7.74%, Including 44.1 metres of 16.81% and 22.3 metres at 17.08% Flake Graphite at La Loutre
Why Harvard is Billionaire University...
Equities.com chats with Ohr Pharmaceutical's (OHRP) Irach Taraporewala and discusses their company's product Squalamine and it's treatment of the wet form of age-related macular degeneration.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2017 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).